Abstract
The secretion of extracellular membrane vesicles (EMVs) is a common phenomenon that occurs in archaea, bacteria, and mammalian cells. EMVs contain biologically active proteins, which have diverse roles in biological processes. The outer membrane vesicles (OMVs) of Gram-negative bacteria and membrane vesicles (MVs) of Gram-positive bacteria have been discovered in various species. The main issues related to bacterial EMVs are their virulence, biogenesis mechanisms, host cell interaction mechanisms, and their potential use as new vaccine candidates. Recently, proteomics has become an essential tool for the characterization of EMVs. Proteomics is useful for the identification, quantification, and protein-protein interaction analysis of EMV protein components. This review describes the current understanding of secretory EMVs based on proteomic methods and the characteristics of various bacterial secretory EMVs. Finally, evidence for their potential roles and future applications are discussed.
Keywords: Extracelluar membrane vesicles (EMVs), membrane vesicles (MVs), outer membrane vesicles (OMVs), proteomics, bacteria.
Current Protein & Peptide Science
Title:Isolation and Proteomic Characterization of Bacterial Extracellular Membrane Vesicles
Volume: 15 Issue: 7
Author(s): Gun-Hwa Kim, Chi W. Choi, Edmond C. Park, Sang-Yeop Lee and Seung II Kim
Affiliation:
Keywords: Extracelluar membrane vesicles (EMVs), membrane vesicles (MVs), outer membrane vesicles (OMVs), proteomics, bacteria.
Abstract: The secretion of extracellular membrane vesicles (EMVs) is a common phenomenon that occurs in archaea, bacteria, and mammalian cells. EMVs contain biologically active proteins, which have diverse roles in biological processes. The outer membrane vesicles (OMVs) of Gram-negative bacteria and membrane vesicles (MVs) of Gram-positive bacteria have been discovered in various species. The main issues related to bacterial EMVs are their virulence, biogenesis mechanisms, host cell interaction mechanisms, and their potential use as new vaccine candidates. Recently, proteomics has become an essential tool for the characterization of EMVs. Proteomics is useful for the identification, quantification, and protein-protein interaction analysis of EMV protein components. This review describes the current understanding of secretory EMVs based on proteomic methods and the characteristics of various bacterial secretory EMVs. Finally, evidence for their potential roles and future applications are discussed.
Export Options
About this article
Cite this article as:
Kim Gun-Hwa, Choi W. Chi, Park C. Edmond, Lee Sang-Yeop and Kim II Seung, Isolation and Proteomic Characterization of Bacterial Extracellular Membrane Vesicles, Current Protein & Peptide Science 2014; 15 (7) . https://dx.doi.org/10.2174/1573403X10666140505163121
DOI https://dx.doi.org/10.2174/1573403X10666140505163121 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ribosome-inactivating Proteins from Root Tubers and Seeds of Trichosan-thes kirilowii and Other Trichosanthes Species
Protein & Peptide Letters A New Interpretative Paradigm for Conformational Protein Diseases
Current Protein & Peptide Science HIV Vaccines: A Global Perspective
Current Molecular Medicine Synthesis and Biological Activity of Chiral Dihydropyrazole: Potential Lead for Drug Design
Mini-Reviews in Medicinal Chemistry Alzheimers Disease and P300: Review and Evaluation of Task and Modality
Current Alzheimer Research Convulsions with Gastroenteritis: Reflections on some Cases and Tentative Diagnostic Score
Current Pediatric Reviews Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human Pathogens
Current Drug Targets Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders
Current Nanoscience Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design Self-Organizing Maps for the Classification of Gallic Acylate Polyphenols as HSV-1 Inhibitors
Medicinal Chemistry Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer's Disease
Current Alzheimer Research Potential Prophylactic and Therapeutic Vaccines for HSV Infections
Current Pharmaceutical Design Plant and Animal Steroids a New Hope to Search for Antiviral Agents
Current Medicinal Chemistry Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses The Urokinase Receptor in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Viral Proteases as Targets for Drug Design
Current Pharmaceutical Design Targeted Blood-to-Brain Drug Delivery – 10 Key Development Criteria
Current Pharmaceutical Biotechnology Delivery Systems for Applications in siRNA Technology
Drug Delivery Letters Specific Roles of NMDA Receptor Subunits in Mental Disorders
Current Molecular Medicine